FOLD Amicus Therapeutics Inc

Amicus Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of next-generation medicines.

$10.04  -0.05 (-0.50%)
As of 09/26/2022 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/31/2007
Outstanding shares:  280,498,461
Average volume:  2,704,353
Market cap:   $2,830,229,471
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B19FQ48
Valuation   (See tab for details)
PE ratio:   -10.48
PB ratio:   11.84
PS ratio:   8.90
Return on equity:   -113.18%
Net income %:   -84.97%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy